| 发明名称 | Cell compositions derived from dedifferentiated reprogrammed cells | ||
| 摘要 | Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions. | ||
| 申请公布号 | US9109245(B2) | 申请公布日期 | 2015.08.18 |
| 申请号 | US201313761078 | 申请日期 | 2013.02.06 |
| 申请人 | ViaCyte, Inc. | 发明人 | Agulnick Alan D.;Kelly Olivia;Ohi Yuki;Robins Allan;Schultz Thomas |
| 分类号 | C12N5/00;C12N5/071;C12N5/07;C07K14/475;C12P21/00;C12N5/10;A61K35/39 | 主分类号 | C12N5/00 |
| 代理机构 | Mintz Levin Cohn Ferris Glovsky and Popeo PC | 代理人 | Mintz Levin Cohn Ferris Glovsky and Popeo PC |
| 主权项 | 1. An in vitro human pancreatic endoderm cell population in a media comprising an ERBB receptor tyrosine kinase activating agent. | ||
| 地址 | San Diego CA US | ||